Pathology Microbiology And Immunology

MBP091, an investigational, anti-Marburg virus antibody identified by Vanderbilt Health researchers and under development by San Diego-based Mapp Biopharmaceutical Inc., was provided to Ethiopian health officials during that country’s first outbreak of the deadly viral infection late last year. Read More

New study from Borden Lacy and Audrey Thomas represents a major step forward for vaccine development for C. diff, the leading cause of health care- and antibiotic-associated infection. Read More

A Middle Tennessee native, Chase Spurlock, PhD’14, was drawn to Vanderbilt University for its excellence in healthcare and science. A project he completed in graduate school ignited in him a desire to impact patient lives through academic-industry partnerships, and he has not looked back since. Read More